Mercury Laboratories
860.00
+27.95(+3.36%)
Market Cap₹99.80 Cr
PE Ratio26.47
IndustryHealthcare
Company Performance:
1D+3.36%
1M-3.15%
6M+6.28%
1Y-8.28%
5Y+93.32%
View Company Insightsright
Latest news about Mercury Laboratories
Mercury Laboratories Reports 183% Jump in Net Profit with Strong Revenue Growth 5 days ago
Mercury Laboratories Limited reported strong financial results for the recent quarter. Total revenue increased by 8.9% to ₹18.32 crore, while net profit after tax surged by 183.3% to ₹96.76 lakh. The EBITDA margin expanded to 13.9% from 10.5%. Revenue from operations grew by 8.7% to ₹18.14 crore. The company's performance was attributed to higher operating leverage, improved cost management, and a favorable product mix. Despite increases in material costs and employee expenses, effective cost control measures led to a 9.4% decrease in other expenses to ₹4.29 crore.